AzTrials
AzTrials

Sexual ViolenceCARENCT06390332

Centering Gender Affirming Resources in Higher Education

A study testing Giving Information for Trauma Support and Safety (GIFTSS) Training and Centering gender Affirming Resources in higher Education (CARE) Learning Modules in people with Sexual Violence and Drinking Heavy, run by University of Pittsburgh at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Centering gender Affirming Resources in higher Education (CARE) project is nested within the parent study "Reducing Alcohol Involved Sexual violence in higher Education" (RAISE; R01 AA023260; NCT05185440). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Sexual Violence, Drinking Heavy
What is being tested?
Giving Information for Trauma Support and Safety (GIFTSS) Training and Centering gender Affirming Resources in higher Education (CARE) Learning Modules
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
11 Dec 2024to 30 Jun 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Those who are seeing undergraduate students at health and counseling appointments as a provider.
  • Providers may include counselors, clinicians, nurses, health educators, medical assistants, social workers, advocates, and administrators.

Who cannot join

  • A college health or counseling center provider that does not interface with students.
  • A college health or counseling center provider not participating in the RAISE study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Regina Futcher, MSW contact

757-272-3783

futcherr2@upmc.edu

Rachel Gartner, PhD contact

412-624-7232

rachelgart@pitt.edu

United States1 site, 1 recruiting
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

    Elizabeth Miller, MD, PhD

    Recruiting

Other trials in United States

About this study

Official title: Inclusive Practices for Gender Minority College Students to Reduce Sexual Violence and Heavy Drinking

Centering gender Affirming Resources in higher Education (CARE) project is nested within the parent study "Reducing Alcohol Involved Sexual violence in higher Education" (RAISE; R01 AA023260; NCT05185440). CARE is a pilot cluster-randomized trial that centers trans and gender diverse (TGD) students who are at elevated risk for SV and hazardous drinking. CARE tests a novel college health and counseling center (CHC) training program designed to improve provider knowledge about TGD individuals, increase their self-efficacy and use of trans-inclusive practices. This includes an evaluation of the feasibility, acceptability, appropriateness, and usability of CARE's training intervention for college health and counseling center providers. This research will produce the first rigorously evaluated TGD-focused CHC provider training which has the potential to increase the accessibility of CHC's for TGD university students- ultimately lowering rates of alcohol use and SV among this disproportionately impacted population.

Read the detailed description

"Centering gender Affirming Resources in higher Education (CARE)" expands upon RAISE's (R01 AA023260) cluster-randomized controlled trial across 28+ college campuses that is evaluating harm reduction interventions to reduce risk for sexual violence (SV) among undergraduate college students receiving care from college health and counseling centers (CHCs). A previous study by this research team found that students identifying as transgender or gender diverse (TGD) report particularly high lifetime prevalence of SV that is associated with greater odds of binge drinking compared to students not exposed to SV. Compounding these vulnerabilities, TGD students face high rates of discrimination on university campuses that drive heavy alcohol use and SV inequities, and lead to distrust of potential support resources like CHCs. CARE enhances RAISE's intervention by employing community-partnered methodologies to develop a training for CHC providers designed specifically to increase their competence in addressing TGD students' health needs with a focus on alcohol use and SV. The training involves a brief e-learning (asynchronous) intervention aimed at improving providers' knowledge and attitudes about TGD individuals, skills in delivering competent and affirming care, and knowledge of and self-efficacy to use TGD-inclusive practices. This trial will assess the feasibility, acceptability, appropriateness, and usability of CARE's training intervention in 15 randomized CHC sites from the parent study (Aim 1). The study will examine CHC provider knowledge and attitudes about TGD individuals, and their knowledge, self-efficacy, and use of TGD-inclusive practices with follow-up at 4-6 months (Aim 2).

Being tested
Giving Information for Trauma Support and Safety (GIFTSS) Training, Centering gender Affirming Resources in higher Education (CARE) Learning Modules
Keywords
Transgender, Gender Minorities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Giving Information for Trauma Support and Safety (GIFTSS) TrainingBehavioural

    Training for college health center staff and clinicians on GIFTSS intervention which is a universal education and brief counseling to address sexual violence prevention and intervention.

  • Centering gender Affirming Resources in higher Education (CARE) Learning ModulesBehavioural

    Training for college health center clinicians and staff on trans and gender diverse (TGD) affirming clinical practices in addition to sexual violence and alcohol abuse prevention that is inclusive of TGD service users

Study groups in NCT06390332
Study groupRoleWhat they receive
Giving Information for Trauma Support and Safety (GIFTSS) TrainingActive comparatorTraining for college health center clinicians and staff in implementation of GIFTSS
Receives: Behavioral: Giving Information for Trauma Support and Safety (GIFTSS) Training
GIFTSS Training and Centering gender Affirming Resources in higher Education (CARE) Learning ModulesExperimentalTraining for college health center clinicians and staff in implementation of GIFTSS combined with CARE's trans learning modules to support implementation with gender diverse service users.
Receives: Behavioral: Giving Information for Trauma Support and Safety (GIFTSS) Training; Behavioral: Centering gender Affirming Resources in higher Education (CARE) Learning Modules

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Provider perception of intervention feasibility

    Domain: Provider-Perceived Feasibility Specific Measurement: Feasibility of Intervention Measure (FIM). Specific Metric: End value Method of Aggregation: Mean score, range 1-5 cutoff mean score > 4, higher score indicates greater feasibility

    Measured: Immediately after CARE training completion

  2. Provider perception of intervention acceptability

    Domain: Provider-Perceived Acceptability Specific Measurement: Acceptability of Intervention Measure (AIM) Specific Metric: End value Method of Aggregation: Mean score, range 1-5, cutoff mean score > 4, higher score indicates greater acceptability

    Measured: Immediately after CARE training completion

  3. Provider perception of intervention appropriateness

    Domain: Provider-Perceived Appropriateness Specific Measurement: Intervention Appropriateness Measure (IAM) Specific Metric: End value Method of Aggregation: Mean score, range 1-5 , cutoff mean score > 4, higher score indicates greater appropriateness

    Measured: Immediately after CARE training completion

  4. Provider perception of intervention usability

    Domain: Provider-Perceived Usability Specific Measurement: System Usability Scale (SUS) Specific Metric: End value Method of Aggregation: Mean score, range 1-5 , cutoff mean score > 4, higher score indicates greater usability

    Measured: Immediately after CARE training completion

Secondary outcomes (14)
  1. Knowledge and attitudes about TGD individuals.

    Domain: Assessing provider knowledge, attitudes, and beliefs about transgender people Specific Measurement: Transgender Knowledge, Attitudes, and Beliefs (T-KAB) scale Specific Metric: End value Method of Aggregation: Mean score, range 1 to 4, 4 indicating favorable attitudes and beliefs towards transgender people

    Measured: Baseline- Before taking CARE training

  2. Knowledge and attitudes about TGD individuals.

    Domain: Assessing provider knowledge, attitudes, and beliefs about transgender people Specific Measurement: Transgender Knowledge, Attitudes, and Beliefs (T-KAB) scale Specific Metric: Change from baseline Method of Aggregation: Mean score, range 1 to 4, 4 indicating favorable attitudes and beliefs towards transgender people

    Measured: At 6 months

  3. Attitudes concerning transphobia

    Domain: Assessing provider's attitudes regarding transphobia Specific Measurement: Transphobia Scale Specific Metric: End value Method of Aggregation: Mean score, range 1 to 7, 7 indicating a lesser degree of transphobia

    Measured: Baseline- Before taking CARE training

  4. Attitudes concerning transphobia

    Domain: Assessing provider's attitudes regarding transphobia Specific Measurement: Transphobia Scale Specific Metric: Change from baseline Method of Aggregation: Mean score, range 1 to 7, 7 indicating a lesser degree of transphobia

    Measured: At 6 months

  5. Human value of transgender people

    Domain: Assessing how providers view the human value of transgender people Specific Measurement: Transgender Attitudes and Beliefs Scale (TABS) Specific Metric: End value Method of Aggregation: Mean score, range 1 to 7, 7 indicating trans and gender diverse people hold high human value

    Measured: Baseline- Before taking CARE training

  6. Human value of transgender people

    Domain: Assessing how providers view the human value of transgender people Specific Measurement: Transgender Attitudes and Beliefs Scale (TABS) Specific Metric: Change from Baseline Method of Aggregation: Mean score, range 1 to 7, 7 indicating trans and gender diverse people hold high human value

    Measured: At 6 months

  7. Use of TGD-inclusive practices

    Domain: Use of transgender and gender diverse-inclusive practices Specific Measurement: The Lesbian, Gay, Bisexual, and Transgender Development of Clinical Skills Scale (LGBT-DOCSS) Specific Metric: End value Method of Aggregation: Mean score, range 1 to 7, 7 indicating high preparedness and knowledge to work with transgender patients

    Measured: Baseline- Before taking CARE training

  8. Use of TGD-inclusive practices

    Domain: Use of transgender and gender diverse-inclusive practices Specific Measurement: The Lesbian, Gay, Bisexual, and Transgender Development of Clinical Skills Scale (LGBT-DOCSS) Specific Metric: Change from baseline Method of Aggregation: Mean score, range 1 to 7, 7 indicating high preparedness and knowledge to work with transgender patients

    Measured: At 6 months

  9. Trans-Inclusivity in professional settings

    Domain: Assessing how trans-inclusive providers are in their practice Specific Measurement: The Trans-Inclusive Provider Scale (TIPS) Specific Metric: End value Method of Aggregation: Mean score, range 1 to 5, 5 indicating high trans-inclusivity in care practices)

    Measured: Baseline- Before taking CARE training

  10. Trans-Inclusivity in professional settings

    Domain: Assessing how trans-inclusive providers are in their practice Specific Measurement: The Trans-Inclusive Provider Scale (TIPS) Specific Metric: Change from Baseline Method of Aggregation: Mean score, range 1 to 5, 5 indicating high trans-inclusivity in care practices

    Measured: At 6 months

  11. Social desirability

    Domain: Measure of social desirability Specific Measurement: Marlowe- Crowne Social Desirability Scale Specific Metric: End Value Method of Aggregation: True and false questions, summary score from 0 to 1

    Measured: Baseline- Before taking CARE training

  12. Social desirability

    Domain: Measure of social desirability Specific Measurement: Marlowe- Crowne Social Desirability Scale Specific Metric: Change from Baseline Method of Aggregation: True and false questions, summary score from 0 to 1

    Measured: At 6 months

  13. Self-Efficacy to use trans and gender affirming practices

    Domain: Self-efficacy to use trans and gender affirming practices Specific Measurement: Investigator Developed Specific Metric: End value Method of Aggregation: Mean score, range 1 to 5, 5 indicating greater self-efficacy to use trans-affirming practices

    Measured: Baseline- Before taking CARE training

  14. Self-Efficacy to use trans and gender affirming practices

    Domain: Self-efficacy to use trans and gender affirming practices Specific Measurement: Investigator Developed Specific Metric: Change from baseline Method of Aggregation: Mean score, range 1 to 5, 5 indicating greater self-efficacy to use trans-affirming practices

    Measured: At 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2024
  2. Study start11 Dec 2024
  3. Primary completion9 Oct 2026
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06390332
Sponsor's protocol ID
STUDY22040105
Other IDs
R01AA023260-07W1
Acronym
CARE
Status last verified
Oct 2026
First submitted
17 Apr 2024
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in